Clinical trial
A Multicentre Randomized Controlled Clinical Study of the Efficacy of Carbon Nanoparticles Versus Indocyanine Green in Surgical Treatment of Colorectal Cancer
NCT04759820 is registered in ClinicalTrials.gov with LI XIN-XIANG as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicentre Randomized Controlled Clinical Study of the Efficacy of Carbon Nanoparticles Versus Indocyanine Green in Surgical Treatment of Colorectal Cancer
- Lead sponsor
- LI XIN-XIANG
- Phase
- Phase 2/3
- Overall status
- Unknown status
- Start date
- January 1, 2021
- Completion date
- June 30, 2023
- Enrollment
- 298 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
number of lymph node retrieved